Clinical trials
Lymphoma, B-Cell, Marginal Zone trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Active, not recruiting | 8 |
| Recruiting | 4 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| NCIC Clinical Trials Group | 3 |
| Alliance for Clinical Trials in Oncology | 2 |
| BeOne Medicines | 2 |
| AbbVie | 1 |
| AbbVie (prior sponsor, Abbott) | 1 |
| Acerta Pharma BV | 1 |
| AstraZeneca | 1 |
| British Columbia Cancer Agency | 1 |
| Celgene | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell, Marginal Zone | 32 |
| Lymphoma, Follicular | 28 |
| Lymphoma, Mantle-Cell | 24 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 21 |
| Lymphoma, Large B-Cell, Diffuse | 18 |
| Lymphoma, Non-Hodgkin | 18 |
| Waldenstrom Macroglobulinemia | 15 |
| Burkitt Lymphoma | 12 |
| Lymphoma, Large-Cell, Immunoblastic | 12 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 12 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.